Dendritic cells (DC) are increasingly used as a vaccine. Unfortunately, a satisfactory
cryopreservation of DC in the absence of FCS is not yet available, so that laborious repeated …

Immune haemolysis as a result of minor ABO incompatibility is an underappreciated
complication of haematopoietic transplantation. The increased lymphoid content of …

Background Studies have shown that stem cell therapy could be a novel option for
improving neovascularization and cardiac function in patients with ischemic heart disease …

Dendritic cells (DCs) are extremely efficient antigen-presenting cells that are potent
stimulators of both B and T cell immune responses. Although DCs are normally present in …

Methods and compositions for use of human dendritic cells to activate T cells for
immunotherapeutic responses against primary and metastatic prostate cancer are disclosed …

Cryopreservation is now considered an integral part of the biotechnological process,
exploiting different types of cells and tissues in clinical practice. Among them, dendritic cells …

The establishment of a cryopreservation method for unstimulated fresh peripheral blood
mononuclear cells (PBMC) with nearly 100% viability would greatly contribute to the conduct …

Human T lymphocytes isolated from peripheral blood were cryopreserved at− 196° C for
different periods of 3, 14, 21, 35, and 50 days. Viability and cytokine-producing activity of T …

To date, phase I/II dendritic cell (DC)-based cancer vaccine trials have required repeated
venesection or leukapheresis to generate the DCs. Previous studies have suggested that …

The success of endovascular techniques such as balloon angioplasty and stenting in the
treatment of atherosclerotic vascular disease has been limited by an aggressive proliferative …